“Over the past 55 years, HST has proven that when engineers, scientists, and clinicians get together, human health leaps ...

Three cancer therapies were among the first two batches of drugs to receive vouchers through a new FDA program.

Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...

A new initiative focuses on strengthening youth engagement in media literacy, promoting ethical AI use, fact-checking skills, ...

Dr. Crocetti discusses a personalized approach to ablation treatment, her work with CIRSE and the EBIR to advance modern ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint ...

Recent research has delved deep into the manifold ways in which diet can affect gut health throughout a person's life. Here ...

GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announced that it will host a virtual key opinion leader (KOL) event ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistan ...

Alto Neuroscience, Inc.'s innovative approach to CNS disorder treatment and 2026 clinical milestones. Click here to find out why ANRO stock is a Buy.

Whitehawk Therapeutics, Inc. , an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer ...

Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise November 24, 2025 9:00 AM ...